These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury. Heller T; Hennecke M; Baumann U; Gessner JE; zu Vilsendorf AM; Baensch M; Boulay F; Kola A; Klos A; Bautsch W; Köhl J J Immunol; 1999 Jul; 163(2):985-94. PubMed ID: 10395696 [TBL] [Abstract][Full Text] [Related]
6. Effects of a new C5a receptor antagonist on C5a- and endotoxin-induced neutropenia in the rat. Short A; Wong AK; Finch AM; Haaima G; Shiels IA; Fairlie DP; Taylor SM Br J Pharmacol; 1999 Feb; 126(3):551-4. PubMed ID: 10188960 [TBL] [Abstract][Full Text] [Related]
7. Species dependence for binding of small molecule agonist and antagonists to the C5a receptor on polymorphonuclear leukocytes. Woodruff TM; Strachan AJ; Sanderson SD; Monk PN; Wong AK; Fairlie DP; Taylor SM Inflammation; 2001 Jun; 25(3):171-7. PubMed ID: 11403208 [TBL] [Abstract][Full Text] [Related]
8. Differential activities of decapeptide agonists of human C5a: the conformational effects of backbone N-methylation. Vogen SM; Paczkowski NJ; Kirnarsky L; Short A; Whitmore JB; Sherman SA; Taylor SM; Sanderson SD Int Immunopharmacol; 2001 Nov; 1(12):2151-62. PubMed ID: 11710544 [TBL] [Abstract][Full Text] [Related]
9. High Concentration of C5a-Induced Mitochondria-Dependent Apoptosis in Murine Kidney Endothelial Cells. Tsai IJ; Lin WC; Yang YH; Tseng YL; Lin YH; Chou CH; Tsau YK Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31510052 [TBL] [Abstract][Full Text] [Related]
10. Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury. Proctor LM; Arumugam TV; Shiels I; Reid RC; Fairlie DP; Taylor SM Br J Pharmacol; 2004 Jun; 142(4):756-64. PubMed ID: 15159277 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist. Strachan AJ; Shiels IA; Reid RC; Fairlie DP; Taylor SM Br J Pharmacol; 2001 Dec; 134(8):1778-86. PubMed ID: 11739255 [TBL] [Abstract][Full Text] [Related]
12. Antagonistic peptides against human anaphylatoxin C5a. Kaneko Y; Okada N; Baranyi L; Azuma T; Okada H Immunology; 1995 Sep; 86(1):149-54. PubMed ID: 7590876 [TBL] [Abstract][Full Text] [Related]
13. IL-4 down-regulates anaphylatoxin receptors in monocytes and dendritic cells and impairs anaphylatoxin-induced migration in vivo. Soruri A; Kiafard Z; Dettmer C; Riggert J; Köhl J; Zwirner J J Immunol; 2003 Mar; 170(6):3306-14. PubMed ID: 12626590 [TBL] [Abstract][Full Text] [Related]
15. Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a. Wong AK; Finch AM; Pierens GK; Craik DJ; Taylor SM; Fairlie DP J Med Chem; 1998 Aug; 41(18):3417-25. PubMed ID: 9719594 [TBL] [Abstract][Full Text] [Related]
16. A functional C5a anaphylatoxin receptor in a teleost species. Holland MC; Lambris JD J Immunol; 2004 Jan; 172(1):349-55. PubMed ID: 14688343 [TBL] [Abstract][Full Text] [Related]
17. Detection of C5a receptors on human eosinophils and inhibition of eosinophil effector functions by anti-C5a receptor (CD88) antibodies. Elsner J; Oppermann M; Kapp A Eur J Immunol; 1996 Jul; 26(7):1560-4. PubMed ID: 8766561 [TBL] [Abstract][Full Text] [Related]
18. Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity. March DR; Proctor LM; Stoermer MJ; Sbaglia R; Abbenante G; Reid RC; Woodruff TM; Wadi K; Paczkowski N; Tyndall JD; Taylor SM; Fairlie DP Mol Pharmacol; 2004 Apr; 65(4):868-79. PubMed ID: 15044616 [TBL] [Abstract][Full Text] [Related]